Introduction
============

Hemoglobin (Hb) is the major protein in the circulating human red blood cells and its main function is to transport oxygen (O~2~). Human Hb is a tetramer composed of two dimers of α-like and β-like globin chains, which differ according to developmental stage. From shortly after early embryonic development up to adulthood, normal human hemoglobins maintain identical α-globin chains, while β-like chains are replaced, as result of two critical switches in gene expression, the first at the embryonic-to-fetal transition and the second at the fetal-to-adult one ([@evt029-B41]; [@evt029-B76]; [@evt029-B72]).

The five human *β-globin* paralogs that code for the different β-like chains are clustered at chromosome 11 together with one pseudogene, being arranged as 5\'-ε(*HBE*)-^G^γ(*HBG2*)-^A^γ(*HBG1*)-ψβ(*HBBP1*)-δ(*HBD*)-β(*HBB*)-3\', in a region extending over approximately 80 kb. The stage-specific expression of each of these genes proceeds sequentially from embryonic (*HBE),* to fetal (*HBG2* and *HBG1*), and finally to adult genes (*HBD* and *HBB*) and relies on the interactions with the locus control region (LCR), located from approximately 6 to 18 kb upstream of *HBE* ([fig. 1](#evt029-F1){ref-type="fig"}*A*) ([@evt029-B12]; [@evt029-B87]; [@evt029-B5]). In adulthood, *HBB* expression levels are much higher than those of its neighbor, *HBD*, resulting in two major Hb tetramers: HbA (α~2~β~2~), which accounts for approximately 97% of the total Hb, incorporates β-chains produced by *HBB*, and HbA~2~ (α~2~δ~2~), the minor fraction of adult Hb (generally \< 3%), which contains the δ-chains encoded by *HBD* ([@evt029-B76]). F[ig]{.smallcaps}. 1.---(*A*) Schematic representation of the *β-globin* cluster located at chromosome 11p15.5. Top: The relative position of the *β-globin* genes and the LCR in the cluster. Bottom: *δ-globin* (*HBD*) and *β-globin* (*HBB*) gene organization (exons are represented by grey squares). The arrows in the lower diagram indicate the extent of the segments surveyed in the resequencing study of the European and African populations. Small black arrows indicate the five *DNase I* hypersensitive sites (HS) encompassed by the LCR located from approximately 6 to 18 kb upstream of *ε- globin (HBE)*. (*B*) *HBD* and *HBB* haplotypes as inferred by PHASE v.2.02. The ancestral state at each site was inferred from ortholog nonhuman primate sequences. From the 25 sites, only 2 lacked a previously associated reference identification code in public databases (dbSNP and Exome Sequencing Project release ESP5400) and were unique to the Portuguese population. Coding variants are labeled. These include the following: one synonymous amino acid replacement in *HBB* (H3H) for the PT population; three synonymous replacements in *HBB* (H3H, L69L, and V134V) for the CEU population; one synonymous replacement in *HBD* (H98H) and one synonymous in *HBB* (H3H) and two nonsynonymous replacements (E7K--HbC allele, E7V--HbS allele) in *HBB* for the YRI population. SNP identifiers as in dbSNP and their chromosomal position based on GRCh37 version are indicated in each column.

Mutations in the β-chain of human HbA are associated with the most common inherited *β-globin* gene disorders world-wide ([@evt029-B97]), such as β-thalassemia ([@evt029-B26]) and sickle cell disease ([@evt029-B59]). On the contrary, HbA~2~, the minor adult Hb, is assumed to be physiologically irrelevant and mutations in *HBD* are per se clinically silent ([@evt029-B81]; [@evt029-B76]). At the functional level, HbA~2~ has features that are nearly identical with those of HbA ([@evt029-B18]) and in the absence of β-chain production, as occurs in patients suffering from β-thalassemia major, HbA~2~ becomes the predominant oxygen carrier. However, HbA~2~ never reaches the amount that would be necessary to effectively replace HbA function ([@evt029-B81]; [@evt029-B29]; [@evt029-B52]), which implies that its levels are only relevant for the diagnosis of *β-globin* disorders. Indeed, an elevated HbA~2~ concentration (≥3.5%) is the most significant parameter in the diagnosis of thalassemia syndromes ([@evt029-B13]; [@evt029-B85]; [@evt029-B26]), justifying the key role that HbA~2~ measurement plays in β-thalassemia screening programs ([@evt029-B29]; [@evt029-B52]).

*HBD*, encoding the unique δ-globin chain of HbA~2~*,* arose via duplication of the *HBB* gene after the marsupial/eutherian split and is therefore unique to placental mammals ([@evt029-B58]). *HBD* has been inactivated or deleted in some lineages ([@evt029-B30]; [@evt029-B33]), but maintained an intact open reading frame in a few primate species, namely in humans, apes, and New World monkeys ([@evt029-B47]; [@evt029-B79]). Human *HBD* and *HBB* show a high degree of homology (93%), as reflected in the similarity of their encoded proteins that only differ in 10 out of 147 amino acids ([@evt029-B81]). Nonallelic gene conversion is the most commonly accepted explanation for such sequence homogeneity, albeit few gene conversion events have been described in the evolution of *HBD* and *HBB* ([@evt029-B62]; [@evt029-B11]).

Given the apparent physiological redundancy of the HbA~2~ protein, the maintenance of *HBD* in several primate lineages is intriguing. Even though we might expect *HBD* to be subject to much lower selective pressure than *HBB*, in a previous study analyzing a small number of African individuals *HBD* was found to have lower diversity levels than *HBB* ([@evt029-B95]). In line with this finding, very few *HBD* mutations causing δ-thalassemia have been described ([@evt029-B81]; [@evt029-B64]). This pattern of sequence conservation, typical of genes under strong evolutionary constraints ([@evt029-B100]), is puzzling given the low expression levels of *HBD* and the presumed negligible functional role of HbA~2~ in oxygen transport ([@evt029-B81]). One possible explanation for this apparent inconsistency could be that genetic variation has been more exhaustively assessed for *HBB* than for *HBD*. Even though the *β-globin* cluster is among the most extensively studied regions in the human genome, current genetic diversity estimates for the *HBD* and *HBB* genes across human populations are likely to be biased, because the genetic analysis of *HBD* and *HBB* has been performed mainly for diagnostic purposes and often based on a set of pre-ascertained single nucleotide polymorphisms (SNPs) ([@evt029-B51]; [@evt029-B45]; [@evt029-B46]; [@evt029-B66]).

In this study, we sought a better understanding of the evolutionary forces acting on *HBD* and *HBB* genes as well as of the physiological relevance of δ-globin conservation in placental mammals. To this end, we performed an unbiased characterization of the genetic diversity at the *β-globin* cluster based on Sanger sequencing of both *HBB* and *HBD* in ethnically diverse samples from Europe and Africa and on the sequence data from the 1000 Genomes Project Consortium ([@evt029-B2]). Then, we have evaluated the patterns of sequence variation, by means of allele frequency spectrum, linkage disequilibrium (LD) and haplotype structure analyses. Finally, we also assessed the diversity levels in this cluster in nonhuman primates using chimpanzee sequence data provided by the PanMap Project. Our findings indicate that purifying selection has shaped the evolutionary history of *HBD* and surprisingly, the same seems to apply to *HBBP1*. Furthermore, we present evidence that strong functional constraints have contributed to reduce the contemporary diversity of these two regions, probably due to a regulatory role in ontogenic switches of gene expression.

Materials and Methods
=====================

Population Samples and Sanger Sequencing
----------------------------------------

Sequence variation for *HBB* and *HBD*, was surveyed in a total of 71 samples: 25 Portuguese samples (PT) were collected in Coimbra's university hospital (Centro Hospitalar e Universitário de Coimbra), from healthy individuals, under informed consent; 46 samples from the International HapMap Project, 23 CEU (Utah residents with Northern and Western European ancestry from the CEPH collection), and 23 YRI (Yoruba from Ibadan in Nigeria). Two DNA fragments of approximately 2 kb, one spanning the entire *HBD* gene and the other the *HBB* gene, were resequenced ([fig. 1](#evt029-F1){ref-type="fig"}*A*). Primers for amplification and sequencing were designed using the latest version of the human genome assembly (GRCh37; <http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/index.shtml>). DNA fragments were amplified using polymerase chain reaction and sequenced with the BigDye Terminator v.3.1 Cycle Sequencing Kit and run on an Applied Biosystems ABI PRISM 3130xl Genetic Analyzer. All sequences were assembled and analyzed using Geneious version 5.4 created by Biomatters (available from <http://www.geneious.com/>) and all putative polymorphisms were manually inspected and individually confirmed.

Data Retrieval
--------------

Data from the 1000 Genomes Project were retrieved from its website (<http://www.1000genomes.org/>). Chromosomal locations and genomic segments from *HBB* (5246599--5248441), *HBD* (5253972--5255850), *HBBP1* (5263085--5265019), *HBG1* (5269347--5271272), *HBG2* (5274263--5276195), and *HBE* (5289469--5291330) were obtained using latest version of the human genome assembly GRCh37. Chimpanzee reference sequence was downloaded from the UCSC Genome Browser (UCSC: <http://genome.ucsc.edu/>) and used as outgroup. Chimpanzee sequence variation was downloaded from PanMap Project website (<http://panmap.uchicago.edu/>). Additionally, we performed a scan for regulatory elements in *HBD--HBBP1* region using data generated by the Encyclopedia of DNA Elements (ENCODE) Consortium ([@evt029-B54]), available in UCSC Genome Browser (<http://genome.ucsc.edu/>) in the Human GRCh37/hg19 assembly.

Statistical Analysis
--------------------

The summary statistics of population genetic variation, number of segregating sites (*S*), nucleotide diversity (π) ([@evt029-B55]), which is based on average number of pairwise differences between sequences; Watterson's estimator of the population mutation rate parameter (θ~W~) ([@evt029-B94]), which is based on the number of segregating sites and sample size, and Tajima's *D* ([@evt029-B84]) and Fay and Wu's H ([@evt029-B22]), which summarizes information about the spectrum of allele frequencies, were calculated using SLIDER (<http://genapps.uchicago.edu/slider/index.html>). To assess the statistical significance of Tajima's *D*, we ran 100,000 coalescent simulations ([@evt029-B39]) using the previously estimated *S* statistic. Simulations were produced with the ''ms'' program, assuming distinct demographic models including constant population size and African and European best-fit models ([@evt029-B75]; [@evt029-B32]). To assess the statistical significance of Fay and Wu's H, we computed 10,000 coalescent simulations in DnaSP v.5.10 ([@evt029-B68]). Haplotypes of *HBB* and *HBD* were inferred using the program PHASE v.2.02 ([@evt029-B83]; [@evt029-B82]). Haplotype data were then annotated with additional SNP information and ancestral allele. Ancestral allele state was retrieved from dbSNP (<http://www.ncbi.nlm.nih.gov/>). LD analyses were performed using Haploview v.4.2 ([@evt029-B9]) and haplotype blocks were identified through the standard algorithm implemented in the software ([@evt029-B25]).

To provide a temporal dimension to the phylogenetic relationships among haplotypes and to estimate the coalescent times and ages of relevant mutations, we used GENETREE v.9.0 ([@evt029-B31]). Since GENETREE assumes no recombination two incompatible haplotypes were removed from the analysis of *HBB*. Time, scaled in 2Ne generations, was derived from θ = 4Neµ. The mutation rate (µ) per gene, per generation, was deduced from the average number of nucleotide substitutions per site between human and chimpanzee reference sequences (Dxy), calculated with DnaSP v.5.10 ([@evt029-B68]). Time estimates in generations were converted into years using a 25-year generation time. Human/chimpanzee divergence was assumed to have occurred 5.4 Ma ([@evt029-B65]).

To infer cladistic (network) relationships among the haplotypes, we used Network v.4.6, applying the Median-Joining method ([@evt029-B4]).

The evolutionary rates per site, per year, and per generation, were deduced from Jukes and Cantor distance calculated with DnaSP v.5.10 ([@evt029-B68]) and assuming the same human/chimpanzee divergence time.

Results
=======

*HBD* and *HBB* Sequence Variation
----------------------------------

We characterized the patterns of variation of the *HBD* and *HBB* genes by surveying two DNA fragments, each one spanning approximately 2 kb covering coding, noncoding, and the flanking 5′ and 3′ regions ([fig. 1](#evt029-F1){ref-type="fig"}). Both segments were resequenced in a total of 71 samples belonging to populations from different geographic origins: Europeans (PT and CEU) and Africans (YRI). Overall, we identified 25 polymorphic sites, including a 2-bp deletion in *HBD* intron 2, which was excluded from further analyses ([fig. 1](#evt029-F1){ref-type="fig"}*B*). In *HBD*, we observed 10 SNPs: 1 synonymous and 9 noncoding; and in *HBB*, we found 14 SNPs including 2 nonsynonymous, 2 synonymous, and 10 noncoding. The two nonsynonymous replacements, identified only in the YRI population, were the HbS (*HBB*:c.20A \> T) and HbC (*HBB*:c.19G \> A) alleles, which are known to confer resistance to *Plasmodium falciparum* and to occur at the highest frequencies in Africa, in endemic areas of malaria ([@evt029-B44]). Contrary to *HBD* in which the low frequency variants (singletons and doubletons) represented 80% of polymorphic sites, the same category of variants in *HBB* included only 36% of the sites. The frequencies for HbS and HbC alleles were 15% and 2%, respectively. The HbS alleles were linked to divergent haplotypes, which are likely to correspond to 3 out of the 5 "classical" β^s^ haplotype backgrounds that are named according to their putative geographical origins (Benin, Bantu, Cameron, Senegal, and Arab) ([@evt029-B61]).

*HBD* and *HBB* Polymorphism Levels and Neutrality Tests
--------------------------------------------------------

Standard population statistics based on the polymorphism levels as summarized by nucleotide diversity (π), and by the estimator of the population mutation rate parameter θ~w~ ([@evt029-B94]) are shown in [table 1](#evt029-T1){ref-type="table"}. Tajima's *D* ([@evt029-B84]) tends to be slightly negative in populations of African descent while it is frequently associated to more positive values in populations of European descent ([@evt029-B91]; [@evt029-B23]; [@evt029-B1]; [@evt029-B80]; [@evt029-B89]). In our data set, Tajima's *D* statistics at *HBD* differs from the common trend showing significantly negative values in all populations analyzed PT, CEU, and YRI ([table 1](#evt029-T1){ref-type="table"}). This result is mainly due to a skew toward low frequency variants in YRI and to the lack of variation in CEU and PT. On the other hand, the Tajima's *D* values estimated for *HBB* are similar in the three populations, moderately negative but nonsignificant ([table 1](#evt029-T1){ref-type="table"}). Table 1Summary Statistics of Population Variation for the Two Adult *β-globin* GenesPopulation*N*[^a^](#evt029-TF1){ref-type="table-fn"}*HBDHBBL*[^b^](#evt029-TF2){ref-type="table-fn"}*S*[^c^](#evt029-TF3){ref-type="table-fn"}π[^d^](#evt029-TF4){ref-type="table-fn"}θ~w~[^e^](#evt029-TF5){ref-type="table-fn"}TD[^f^](#evt029-TF6){ref-type="table-fn"}*LS*πθ~w~TDPT501,87910.211.18−1.10[\*](#evt029-TF7){ref-type="table-fn"}1,84377.828.49−0.21CEU461,87910.231.21−1.11[\*](#evt029-TF7){ref-type="table-fn"}1,84388.239.89−0.46YRI461,87984.559.66−1.53[\*\*](#evt029-TF8){ref-type="table-fn"}1,84398.1111.12−0.77[^2][^3][^4][^5][^6][^7][^8][^9]

To confirm the significant departure of *HBD* from the expectations under the neutral equilibrium we generated theoretical null distributions for calibrated models of human demography by coalescent simulations ([@evt029-B75]; [@evt029-B32]). The significant results obtained with such tests ([table 1](#evt029-T1){ref-type="table"}) provide arguments for a nondemographic interpretation of the low variation levels at *HBD*. In addition, the diversity patterns observed at the adjacent gene (*HBB*) seem to favor a selective hypothesis for the evolution of *HBD* rather than a population expansion that would have affected both genes equally. Two alternative selective hypotheses could explain the significant departure from neutrality of *HBD*: first, strong purifying selection that would purge any new deleterious mutations and second, a complete selective sweep in which an advantageous variant reached fixation. Considering the functional redundancy of HbA~2~, it is difficult to accept a protein modification as the likely target for positive selection. The single fixed difference in *HBD* between humans and great apes replaces two functionally equivalent amino acids, a valine by methionine (V127M) and it is already present at the Denisova sequence ([@evt029-B67]; [@evt029-B50]). This gives a minimum time frame of 600,000--800,000 years for the origin of M127, which would be incompatible as well with a recent complete selective sweep. The possibility of a noncoding variant under positive selection cannot be excluded; however in that scenario, we would expect other typical features of selection like long and homogeneous haplotypes, high levels of population differentiation and unusual patterns of diversity given the observed divergence, which were not detected ([@evt029-B40]; [@evt029-B22]; [@evt029-B69]; [@evt029-B99]; [@evt029-B49]), as further described below.

Gene Genealogy and Age Estimates of *HBD* and *HBB*
---------------------------------------------------

We reconstructed the gene genealogy of *HBD* and *HBB,* and estimated the time to the most recent common ancestor (*T*~MRCA~) using a maximum likelihood coalescent analysis ([@evt029-B31]). The results represented in [figure 2](#evt029-F2){ref-type="fig"}, reveal that the tree of *HBD* differs sharply in its topology from that of *HBB*. Theoretically, *HBD* tree shape could be attributed either to population expansion, to positive or background selection ([@evt029-B36]; [@evt029-B3]; [@evt029-B86]). The estimated *T*~MRCA~ of *HBD*, 0.73 ± 0.33 Myr, is much younger than the estimated for *HBB* (1.12 ± 0.41 Myr), the latter being in full agreement with both observed and expected *T*~MRCA~ for human autosomal genes ([@evt029-B21]; [@evt029-B86]; [@evt029-B28]; [@evt029-B43]). Given the previous findings and the rejection of a demographic hypothesis, these results provide further support for a nonneutral interpretation of *HBD* evolution. The contrasting tree structure and recent *T*~MRCA~ of *HBD* relative to *HBB*, can instead be more parsimoniously attributed to strong purifying selection, which is expected to show more recent coalescence times than under neutrality ([@evt029-B3]). F[ig]{.smallcaps}. 2.---*HBD* and *HBB* gene genealogies as estimated by Genetree. Time is scaled in millions of years (Myr). Solid circles represent nucleotide substitutions. The number below each branch of the trees represents the chromosomes observed for each haplotype, and in the lower diagram this information is split by population.

*β-Globin* Gene Cluster Diversity Patterns
------------------------------------------

To obtain a more comprehensive assessment of the patterns of diversity on the entire *β-globin* gene cluster, we analyzed the data available from the 1000 Genomes Project phase 1 release v.3 ([@evt029-B2]), generated from the genome sequencing of 1,092 individuals belonging to 14 populations and five major populations groups: African, European, American, and East and South Asian ([supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) online). We first analyzed the patterns of LD in the 80 kb region encompassing the entire *β-globin* cluster, in the populations resequenced in our study (CEU and YRI) ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) online). We observed in the full *β-globin* cluster two distinct regions with strong LD, one that contains *HBB* (LD region 1) and the other extending from *HBD* to the LCR (LD region 2). These two regions are separated by a segment that encompasses one of the first recombination hotspots identified in humans ([@evt029-B15]; [@evt029-B77]; [@evt029-B90]). Then, we evaluated the polymorphism levels for the five *β-globin* cluster genes comprised in the LD region 2: *HBD, HBE*, *HBG2*, *HBG1,* and *HBBP1*, and for *HBB,* included in LD region 1. As shown in [table 2](#evt029-T2){ref-type="table"}, summary statistics of CEU and YRI populations are in agreement with the results from our resequencing study. In the complete 1000 Genomes data set, higher nucleotide diversity levels were observed in African populations (YRI, LWK, and ASW) ([table 2](#evt029-T2){ref-type="table"} and [supplementary file S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) online). Notwithstanding, *HBD* consistently displayed reduced levels of nucleotide diversity and strongly negative Tajima's *D* values when compared with the remaining *β-globin* cluster genes, independently of the population studied ([table 2](#evt029-T2){ref-type="table"} and [supplementary file S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) online). Interestingly, *HBBP1* sequence, 7 kb upstream of *HBD,* is also one of the less diverse regions in the cluster, only surpassed by *HBD* and *HBE*, the latter encoding the extremely conserved embryonic globin. Thus, diversity patterns observed for *HBD* and *HBBP1* suggest strong evolutionary constraints not related to protein function, as both are either marginally or not transcribed at all. Finally, we used the 1000 Genomes data to perform a sliding-window analysis of variation over the genomic region covering the entire *β-globin* cluster. As shown in [figure 3](#evt029-F3){ref-type="fig"}, the genomic regions corresponding to *HBD* and *HBBP1* presented the lowest values of both nucleotide diversity and Tajima's *D*, only comparable with those obtained for the LCR region. Noteworthy, the intergenic region flanked by *HBBP1* and *HBD* shows the opposite trend, with high levels of nucleotide diversity and positive Tajima's *D* values, suggesting a complex evolutionary history possibly shaped by a noncanonical gene function. F[ig]{.smallcaps}. 3.---Sliding window analysis of the genomic region encompassing the *β-globin* gene cluster. Data were obtained from 1000 Genomes Project, representing 1,092 individuals from 14 populations: three African (ASW, LWK, and YRI), five European (CEU, FIN, GBR, IBS, and TSI), three Asian (CHB, CHS, and JPT) and three American-admixed populations (CLM, MXL, and PUR). Both π (*A*) and Tajima's *D* (*B*) were calculated in 2 kb windows with increments of 150 bp. Table 2Summary Statistics of Population Variation for the *β-globin* Cluster Genes Using the 1,000 Genomes Project Data*L*[^a^](#evt029-TF9){ref-type="table-fn"}CEUYRI*N*[^b^](#evt029-TF10){ref-type="table-fn"}*S*[^c^](#evt029-TF11){ref-type="table-fn"}π[^d^](#evt029-TF12){ref-type="table-fn"}θ~w~[^e^](#evt029-TF13){ref-type="table-fn"}TD[^f^](#evt029-TF14){ref-type="table-fn"}*N*[^a^](#evt029-TF9){ref-type="table-fn"}*S*[^c^](#evt029-TF11){ref-type="table-fn"}π[^d^](#evt029-TF12){ref-type="table-fn"}θ~w~[^e^](#evt029-TF13){ref-type="table-fn"}TD[^f^](#evt029-TF14){ref-type="table-fn"}*HBB*1,84317078.286.650.53176118.4910.39−0.44*HBD*1,87940.313.73−1.67106.539.26−0.70*HBBP1*1,935118.759.96−0.29146.1512.59−1.30*HBG1*1,9261011.799.090.711821.7816.270.90*HBG2*1,9331117.479.971.831622.0914.411.39*HBE*1,86245.393.760.79137.3912.15−0.98[^10][^11][^12][^13][^14][^15]

*HBBP1*, *HBD*, and *HBB* Haplotype Analysis
--------------------------------------------

We next focused on the comparison of the haplotype structure of the two adult genes, *HBD* and *HBB*. *HBBP1* was also included in the analysis because of the unusual low levels of diversity presented by this pseudogene. We reconstructed haplotype genealogies for *HBB*, *HBD,* and *HBBP1* using the full data set of the 1000 Genomes project. For *HBD,* a single common haplotype with an 88% frequency was identified. The star-shaped structure observed in the *HBD* network ([supplementary figs. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) and [S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) online) is in agreement with the atypical genetree of *HBD* built with our own resequencing data (CEU, PT, and YRI). Overall, these results give further support to the hypothesis of strong purifying selection operating on *HBD*, irrespectively of the diverse population demographic histories. The haplotype network for *HBBP1* might be consistent with purifying selection as well, even though its footprints are somewhat weaker than those at *HBD*.

Interspecies Comparisons
------------------------

To gain further insight into the possible functional constraints that have been shaping the evolutionary history of this genomic region, we used human and chimpanzee sequences to calculate and compare the rate of divergence, in exons and introns, across *HBD*, *HBB,* and *HBBP1* ([table 3](#evt029-T3){ref-type="table"}). In *HBB*, introns display an evolutionary rate ∼7 times higher than exons. Although higher divergence rates are expected for introns, in the case of *HBB* this likely reflects an increased intronic mutation rate as reported for *β-globin* genes (1.89%), when compared with the intronic average (1.03%) ([@evt029-B17]). Remarkably, *HBD* and *HBBP1 Homo--Pan* nucleotide differences are more homogeneously distributed between exons and introns, and the overall substitution rate is nearly half of that observed for *HBB* introns ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) online), indicating again that these genes are under higher evolutionary constraints. Table 3Evolutionary Rates Based on Jukes--Cantor DistanceExonsIntronsDiv[^a^](#evt029-TF15){ref-type="table-fn"}Mutation Rate[^b^](#evt029-TF16){ref-type="table-fn"}Div[^a^](#evt029-TF15){ref-type="table-fn"}Mutation Rate[^b^](#evt029-TF16){ref-type="table-fn"}YearGenerationYearGeneration*HBD*0.800.74 × 10^−9^1.84 × 10^−8^0.990.91 × 10^−9^2.28 × 10^−8^*HBB*0.260.24 × 10^−9^0.60 × 10^−8^1.751.62 × 10^−9^4.06 × 10^−8^*HBBP1*1.451.34 × 10^−9^3.36 × 10^−8^1.040.96 × 10^−9^2.41 × 10^−8^[^16][^17]

We next evaluated the haplotype diversity for these 3 genes in chimpanzees, by using sequence variation data from 10 Western chimpanzees (*Pan troglodytes verus*) generated by the PanMap Project ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) online), which has revealed that *HBD* and *HBBP1* presented lower nucleotide diversity relative to *HBB*. These results resemble those obtained for the different human populations, and therefore it seems likely that *HBD* and *HBBP1* are under purifying selection also in chimpanzees.

Scan for Regulatory Elements in *HBD--HBBP1* Region
---------------------------------------------------

The low levels of diversity found in *HBD* and *HBBP1* suggest that both sequences are evolving under purifying selection which cannot be attributed to constraints on a functional protein. An alternative explanation is that *HBD* and *HBBP1* lie within crucial regions for the regulation of gene transcription, in which selective pressures would be acting to maintain the nucleotide sequence. To explore this possibility, we analyzed the data generated by the Encyclopedia of DNA Elements (ENCODE) Consortium ([@evt029-B54]), available through the UCSC Genome Browser (<http://genome.ucsc.edu/>). A large number of transcription factor binding sites have been experimentally detected by ChIP-seq throughout the *β-globin* cluster, some of which with an established role in chromatin remodeling, namely the zinc finger protein (CTCF--CCCTC-binding factor), the C2H2 type zinc-finger protein (BCL11A) and the globin transcription factor 1 (Gata-1) ([@evt029-B88]; [@evt029-B78]; [@evt029-B38]; [@evt029-B98]). Previous studies have also analyzed the long-range chromatin interactions in the *β-globin* cluster by Chromosome Conformation Capture Carbon Copy (5C) ([@evt029-B19]; [@evt029-B74]) ([supplementary fig. S4*A*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) online). Noteworthy, significant interactions were detected between a segment comprising both *HBD* and *HBBP1*, and different regions upstream *HBE*, which overlap the LCR. Moreover, these interactions were detected specifically in the erythropoietic cell line K562, in which *β-globin* genes are actively transcribed. Interestingly, in this cell line both the LCR and *HBD* lie in regions of open chromatin, as determined by DNAse I hypersensitivity and FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) assays, two different methods to identify nucleosome-depleted regions of the genome ([supplementary fig. S4*B*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt029/-/DC1) online). The specific conformation observed in K562 cells suggests that this structure has a role in maintaining an active transcriptional state of the *β-globin* cluster in this cell line. In fact, both *HBD* and *HBBP1* may act as anchor regions in LCR-driven chromatin looping, a crucial mechanism for temporal coordination of gene expression in the human *β-globin* cluster ([@evt029-B12]; [@evt029-B63]).

Discussion
==========

Unusual low levels of diversity have been described for human *HBD,* which are difficult to reconcile with the negligible function of HbA~2~ in oxygen transport ([@evt029-B95]). In primates *HBD* exhibits a surprisingly high level of sequence conservation relative to functional paralogs ([@evt029-B81]), suggesting an important role of *HBD* in those lineages. Here, we gain insight into the evolutionary history of *HBD* and its potential function in gene regulation by performing a detailed analysis of the sequence diversity and divergence of the *β-globin* cluster in humans and chimpanzees. Our results demonstrate that the *HBD* lack of diversity is a common trend across human populations that cannot be due neither to a systematic bias of clinical studies nor to an effect of population history. Even though recent evidence point to a human explosive growth over the past 10,000 years leading to an increment in very low frequency variants ([@evt029-B42]), the significance of the negative Tajima's *D* values obtained under the best-fit models discourage a demographic interpretation of *HBD* diversity. Furthermore, the findings of strong negative Tajima's *D* values in the absence of other features of positive selection, pinpoint *HBD* as a target of purifying selection like previously reported for innate-immunity genes under strong functional constraints ([@evt029-B8]; [@evt029-B53]; [@evt029-B96]).

An atypical tree topology was identified for *HBD* consistent with the loss of mild deleterious variants by negative selective pressures and a low *T*~MRCA~ of 0.73 ± 0.33 Myr (or 0.58 ± 0.26 Myr for a generation time of 20 years), amongst the most recent estimates obtained for autosomal genes (0.20--0.31 Myr for a generation time of 20 years), was confirmed ([@evt029-B24]; [@evt029-B48]; [@evt029-B21]; [@evt029-B86]; [@evt029-B95]; [@evt029-B28]; [@evt029-B43]). Conversely, the polymorphism levels and *T*~MRCA~ estimate obtained for *HBB* are in agreement with the expectations under a neutral model and do not differ from previous studies ([@evt029-B34]).

Taken together, the results obtained for the *β-globin* cluster cannot be reconciled with other explanatory hypotheses rather than purifying selection: the low values of nucleotide diversity are confined to *HBD* and *HBBP1* and do not extend into the flanking regions which display contrastingly high levels of variation; the haplotype structure of *HBD* and *HBBP1* are similar across worldwide populations; furthermore, chimpanzee *HBD* and *HBBP1* also exhibit lower haplotype diversity than *HBB* and their mutation rates, as inferred from human--chimpanzee divergence, are considerably reduced when compared with *HBB* and to other *β-globin* noncoding regions ([@evt029-B17]). Evidence here presented suggests a long-term effect of purifying selection probably predating modern human origins (200,000 years), with the same strong functional constrains acting across different primate species for at least 5 Myr.

Several decades ago, a hypothesis was formulated holding an important regulatory role of *HBD* and *HBBP1* in the Hb fetal-to-adult switch that matches quite well the assumption of strong negative selective forces acting on these sequences ([@evt029-B60]; [@evt029-B6]; [@evt029-B16]; [@evt029-B30]). Over the past years, the *β-globin* cluster has been regarded as a complex genetic system and a paradigm of gene expression regulation. More recently, a boost of studies on the *β-globin* cluster have contributed to a better understanding of the mechanisms underlying the regulation of each gene in the cluster ([@evt029-B35]; [@evt029-B14]; [@evt029-B57]; [@evt029-B72]). Remarkably, chromosome conformation (3C and 5C) analyses for the *β-globin* locus disclosed strong interactions between the LCR and the region encompassing both *HBD* and *HBBP1* ([@evt029-B19]; [@evt029-B74]). Furthermore, distinct spatial interactions of the LCR in fetal and adult stages were uncovered by another study based only in 3C assay in which *HBD* sequence was proposed to be enrolled in the maintenance of a transcriptionally competent structure at the adult stage ([@evt029-B10]). These recent findings suggest that *HBD* and *HBBP1* might be involved in chromatin looping in the human *β-globin* cluster, a crucial mechanism for temporal coordination of gene expression ([@evt029-B37]). Importantly, one SNP (rs10128556) in *HBBP1* has been also identified as a modulator of HbF levels reinforcing the idea that this genomic region is indeed involved in the Hb fetal-to-adult switch ([@evt029-B27]). Considering that the mechanism of Hb switch is common to all simian primates ([@evt029-B41]), we might expect to find similar patterns of conservation and diversity in orthologous sequences of *HBD* and *HBBP1* and to detect signatures of purifying selection at the *β-globin* cluster over 40 Myr of primate evolution.

In contrast to the low diversity levels of *HBD* and *HBBP1* are the high levels found in the *HBD-HBBP1* intergenic region. This pattern has been previously observed in a study involving 23 individuals from the Luo population (Kenya, Africa) ([@evt029-B95]). There, the authors found a significant positive Tajima's *D* and two divergent haplotypes "R" and "T" regarded either as relics of a subdivided ancestral hominid population or as a signature of balancing selection ([@evt029-B101]; [@evt029-B102], [@evt029-B95]). It is known that the *HBD*--*HBBP1* intergenic region contains a small segment of 1 kb flanked by two opposite orientated Alu elements, which is expected to increase genetic instability and local mutation rate ([@evt029-B92]), therefore providing an explanation for the observed high diversity levels. Also of note, is the fact that a 3.5 kb segment upstream of *HBD* was proven to be necessary for *HBG1* and *HBG2* gene silencing since its deletion causes an increment in HbF production throughout adulthood ([@evt029-B71]). This segment overlaps a binding region of BCL11A, which is a biochemically validated and fundamental switching factor ([@evt029-B70], [@evt029-B73]), and contains other functional elements, such as a polypyrimidine tract that can serve as a binding site for multiprotein chromatin remodeling complexes ([@evt029-B7]). Furthermore, it has been demonstrated that the binding of protein complexes in this region induces conformational changes in the *β-globin* cluster, which in turn mediate long-range physical interactions between distal regulatory elements located in the LCR ([@evt029-B98]). Therefore, we propose that the two alternative haplotype configurations "R" and "T" may represent nucleotide combinations that preserve specific motifs for binding of protein complexes involved in transcriptional regulation and chromatin remodeling.

Collectively, these findings illustrate the complexity of the regulatory mechanisms within the cluster and provide a rationale for the heterogeneity in diversity levels observed within the *HBD*--*HBBP1* region. In the yeast genome, higher conservation was observed in nucleosome free regions, compared with regions with high nucleosome occupancy, irrespective of their overlap with coding sequences, which underscores the correlation between chromatin structure and evolutionary constraints ([@evt029-B56]). Accordingly, a recent study integrating ENCODE and 1000 Genomes data uncovered a widespread signature of purifying selection on regulatory regions in humans, including promoters, enhancers, insulators and other regions with different chromatin conformational states ([@evt029-B93]). The authors also noticed that many of these regions are lineage specific and a fraction of these arose in the common ancestor of primates. We hypothesize that the clear signature of purifying selection at *HBD* and *HBBP1* may reflect constraints on local chromatin conformation and the maintenance of a nucleosome free region available for frequent interactions with the LCR.

In summary, the results here presented indicate that purifying selection is driving not only *HBD* evolution but also its neighbor pseudogene, *HBBP1*. In the light of recent advances in the characterization of the *β-globin* cluster, we propose that the complex patterns of diversity observed in this genomic region arose from distinct functional constraints related with the intricate process of chromatin and protein interactions coordinating the differential expression of genes at the *β-globin* cluster during development.
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